
RUPERTO NICOLINO
Pubblicazioni
Eloseily, E., Pickering, A., Dhakal, S., Ruperto, N., Brunner, H., Grom, A., et al. (2025). Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction. ARTHRITIS CARE & RESEARCH, 77(4 (April 2025)), 513-521 [10.1002/acr.25459]. Dettaglio
Naddei, R., Ridella, F., Bovis, F., Trincianti, C., Avrusin, I., Januskeviciute, G., et al. (2025). Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score. RHEUMATOLOGY, 64(4), 2143-2152 [10.1093/rheumatology/keae326]. Dettaglio
Tarkiainen, M., Balay-Dustrude, E., Consolaro, A., Morgan, E., Ruperto, N., Rypdal, V., et al. (2025). Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus. ARTHRITIS CARE & RESEARCH, 77(4), 528-533 [10.1002/acr.25447]. Dettaglio
Mayer, A., Brandon, T., Aggarwal, A., Burgos-Vargas, R., Colbert, R., Horneff, G., et al. (2025). Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis. THE JOURNAL OF RHEUMATOLOGY, 52(2), 165-172 [10.3899/jrheum.2024-0696]. Dettaglio
Bustaffa, M., Bella, S., Bayindir, Y., Amaryan, G., Gallizzi, R., Papadopoulou-Alataki, E., et al. (2025). Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study. JOURNAL OF AUTOIMMUNITY, 153(May 2025) [10.1016/j.jaut.2025.103421]. Dettaglio